Hematologic Malignancies Market Is Predicted To Grow Swiftly Due To The Increasing Investment In Cancer Research Till 2025: Grand View Research, Inc.

The global hematologic malignancies market is estimated to reach USD 85.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of hematologic malignancies and presence of a strong product pipeline are estimated to boost the market. Moreover, increasing number of mergers and acquisitions are also expected to accelerate growth.

Furthermore, governments of developing countries are spending more on healthcare and on improving healthcare infrastructure. This is likely to reduce out-of-pocket expenditure for patients. which is considered as one of the major factors driving the hematologic malignancies market.

Recently it has been seen that the government sources are taking an initiative in funding the institutes for breakthrough oncology research. This is a major growth driver for the market as it will support the institutes to conduct their research on a larger-scale without any financial constraints. Federal government funding for research in oncology has led to a substantial development in cancer detection, prevention, diagnosis, treatment and quality of life for patients. Due to the advancement in cancer research, more patients with cancer are being successfully treated. The increasing investment in cancer research is expected to boost the growth of market during forecast period

U.S. hematologic malignancies market by type, 2014 – 2025 (USD Billion)

 

hemo2.jpg

Browse full research report on Hematologic Malignancies Market: http://www.grandviewresearch.com/industry-analysis/hematologic-malignancies-market

Further Key Findings From the Study Suggest:

  • Multiple myeloma is expected to be one of the fastest growing segments over the forecast period owing to strong pipeline of blockbuster products
  • Chronic myeloid leukemia was identified as the largest leukemia subtype in 2016 due to availability of large number of products and high number of target population
  • Chemotherapy held the largest share in 2016 on the basis of therapy due to its preference as first line of therapy and wide product range
  • Immunotherapy is anticipated to be the fastest growing segment and this can be attributed to lower adverse effects and higher efficiency
  • North America dominated the market in 2016 owing to local presence of key players and increasing number of mergers and acquisitions
  • Asia Pacific is expected to be the fastest growing region over the next decade with lucrative CAGR from 2017 to 2025 due to improving economic conditions and rising healthcare expenditure
  • Some of the key players are Pfizer, Inc.; F. Hoffmann-LA Roche Ltd; Sanofi; Bristol-Myers Squibb Company; AbbVie, Inc.; Novartis AG; GlaxoSmithKline PLC; Celgene Corporation; Johnson & Johnson Services, Inc.; and Takeda Pharmaceutical Company Limited
  • Most of the key players are focusing on expanding their product portfolios, development of new treatment, and acquisitions.

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-hematologic-malignancies-market                                                                                             

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

Advertisements

Artificial Intelligence Market Is Predicted To Grow Swiftly Due To Risisng Demand For Smartphone Technology Till 2025: Grand View Research, Inc.

The global artificial intelligence market is expected to reach USD 35,870.0 million by 2025 from its direct revenue sources, growing at a CAGR of 57.2% from 2017 to 2025, whereas it is expected to garner around USD 58,975.4 million by 2025 from its enabled revenue arenas, according to a new report by Grand View Research, Inc.

Artificial Intelligence (AI) is considered to be the next stupendous technological development, alike past developments such as the revolution of industries, the computer era, and the emergence of smartphone technology. The North American region is expected to dominate the industry due to the availability of high government funding, the presence of leading players, and strong technical base. Advances in image and voice recognition are driving the growth of the artificial intelligence market as improved image recognition technology is critical to offer enhanced drones, self-driving cars, and robotics. The AI market can be categorized based on solutions, technologies, end use, and geography.

The two major factors enabling market growth are emerging AI technologies and growth in big data espousal. The growing prominence of artificial intelligence is enabling new players to venture into the market by offering niche application-specific solutions. Furthermore, companies are also engaging in industry consolidations in a bid to gain competitive advantages. For instance, in January 2017, Microsoft Corporation acquired Maluuba for advancing in the deep learning and Artificial Intelligence (AI) landscape. Existing solution providers are innovating their product portfolio to include both hardware and software solutions.

The Asia Pacific regional market is expected to be the fastest-growing market, owing to the rapid improvements in information storage capacity, high computing power, and parallel processing, which have contributed to the swift uptake of artificial intelligence technology in end-use industries such as automotive and healthcare.

AI has the potential to reduce the burden on clinicians and provide an efficient tool to workforces for accomplishing their tasks in a better way. For instance, AI voice-enabled symptom checkers can better access a situation and assist patients to the emergency department when immediate treatment is required. AI is expected to resolve around 20% of unmet healthcare demands.

Artificial Intelligence – Direct & Enabled Revenue, 2014 – 2025 (USD Million)

artificial-Intelligence-market.png

Browse full research report on Artificial Intelligence Market: http://www.grandviewresearch.com/industry-analysis/artificial-intelligence-ai-market

Further Key Findings From the Study Suggest:

  • Growth in the volume of data being generated from different end-use industries is expected to provide traction to the technology adoption
  • The increasing adoption of image and pattern recognition in the Asia-Pacific region is expected to provide new growth opportunities over the forecast period.
  • The North America region is one of the early adopters of advanced technologies and renders organizations to adopt artificial intelligence capabilities at a faster pace.
  • The increasing amount of digital data (in the form of speech, videos, and images, from different social media sources such as IoT and consumer analytics) is driving the need for data mining and analytics. AI is extensively used by several media and online services such as Google Assistant, dialogue and voice recognition of Siri, Microsoft Cortana, image classification in Facebook & Google Photo, and Amazon’s Alexa.
  • The key industry participants include Atomwise, Inc., Lifegraph, Sense.ly, Inc., Zebra Medical Vision, Inc., Baidu, Inc., H2O ai, IBM Watson Health, NVIDIA, Enlitic, Inc., Google, Inc., Intel Corporation, and Microsoft Corporation.

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-artificial-intelligence-ai-market                                                                                            

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

Liquid Biopsy Market Is Projected To Reach $5.96 Billion By 2030: Grand View Research, Inc.

Global liquid biopsies market is anticipated to reach 5,958.3 million by 2030, according to a new report by Grand View Research, Inc. As these less invasive biopsies are able to address a number of significant challenges associated with conventional biopsies such as, high level of invasiveness, incompleteness of cancer information that is acquired, associated post-biopsy serious medical complications, and subsequent cost inclusions. A growing need for more advanced, efficient and accurate method which provides a holistic view of the tumor and metastasis is the prime factor fueling rapid development of liquid biopsies.

The market has gained considerable traction in the past couple of years. A number of clinical research projects related to circulating tumor cells, and cell-free tumor DNA have been initiated in the latter half of the past decade. As a result, there are a number of ongoing clinical trials that are due to be completed between post 2017-18. It is expected that upon successful completion, commercialization of these assays and tests will provide the market a significant boost in potential addressable target revenue and fuel growth through to 2030.

U.S. liquid biopsy market, by application, 2013 – 2030 (USD Million)

 

liquid-biopsy-market.png

 

Browse full research report on Liquid Biopsy Market: http://www.grandviewresearch.com/industry-analysis/liquid-biopsy-market

Further Key Findings From the Study Suggest:

  • In terms of applications, therapy selection of metastatic cancers is the key area of liquid biopsy usage as these provide significant insights into the unique genetic information encoded in CTCs and ctDNAs. Furthermore, with the addition of more research data reinforcing the usage of liquid biopsies over the coming years, it is expected that their application for molecular monitoring of diseases will also be a lucrative source of revenue through to 2030
  • Key biomarkers that any liquid biopsy targets include circulating tumor cells, circulating tumor DNA and exosomes that are macrovesicles containing tumor RNA, or tumor protein freely circulating in the patient’s bloodstream. Assays for ctDNA are expected to account for the largest share of revenue through to 2030 owing to the currently present assays and expected number of products that are to be commercialized over the coming decade.
  • Development of parallel multi-gene analysis using next generation sequencing technology is the underlying factor that has enabled oncologists to more efficiently sequence ctDNA and gain insights related to cancer metastasis and the related mechanism. This understanding provides a patient-centric systemic view of cancer and aids in its long term monitoring.
  • North America, specifically the U.S. accounts for the largest share of revenue for the development of liquid biopsy market. The region was observed to account for around 50% of the global potential in 2015 owing to the high number clinical development projects underway for the commercialization of CTC and ctDNA assays till 2020. Furthermore, throughout the forecast period, U.S. is expected to dominate revenue generation owing to the dynamic nature & being the region of prime activity, research and development with respect to liquid biopsy and next generation sequencing technology.
  • Although, post successful commercialization through to 2030, Asia Pacific is expected to be a lucrative region for development as it is expected to be characterized by the presence of a large patient population base, developing healthcare framework and growth in integration of more advanced healthcare practices.
  • The market is in its developing phase and is characterized by the presence of a number of relatively smaller entities involved in innovation and new product development. Companies such as Biocept, Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Qiagen, Personal Genome Diagnostics, Cynvenio, RainDance Technologies, and Trovagene are operating in the space and have a number of commercialized assays in their portfolios for liquid biopsy.
  • Furthermore, as this space has a high lucrative potential, and is considerably influenced by the developments in NGS technology, there are a number of major players that have ongoing investigational & observational clinical trials and are due to be completed by 2017 to 2019. Collectively, over 30 clinical trials are currently registered as active by companies including Illumina, Foundation Medicine, Natera Inc., Roche, Sequenom, LabCorp, Epic Sciences, and Pathway Genomics in the U.S. alone. Anticipated successful commercialization of these products is expected to fuel growth over the forecast period.

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/liquid-biopsy-market                                                                                           

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

Regenerative Medicine Market Is Anticipated To Reach $5.59 Billion By 2025: Grand View Research, Inc.

The global regenerative medicine market size is expected to reach USD 5.59 billion by 2025, according to a new report by Grand View Research, Inc. Increased prevalence of neurodegenerative, orthopedic, and other aging-related disorders in geriatric population coupled with rising global geriatric population is anticipated to drive market growth.

Developments in biotechnology have enabled gaining in-depth knowledge pertaining to cell division and differentiation as well as the metabolism mechanism of various cells. This enriched knowledge, coupled with emergence of novel streams of biotechnology such as gene therapy and nanotechnology, further prospered use of cell-based technology in therapeutic treatment.

Well established regenerative approached for various dermatological indications exists since ages. Technological advances introduced scaffolds, matrices, and grafts engineered for faster regeneration and minimal surgical procedure.

Identification of ability of stem cells to develop into various different cell lines further propelled the advancements in regenerative medicine. Frequent media exposure due to regulatory as well as ethical controversies around embryonic stem cells has increased awareness among the masses. This encouraged researchers to explore and develop other potential fields for similar applications, such as induced pluripotent stem cells (iPSC).

Furthermore, the emergence of gene therapy techniques with potential to rectify and restore effects of gene mutations in cells is under development. Conditions caused due to Single Nucleotide Polymorphism (SNP) as well as mutations that induce degenerative characteristics are primarily targeted.

Biologics, individually or in combination with cells or devices, are explored to support regenerate the biological functions of cells, tissues, or organs. A number of combinatorial therapies to support chemotherapy and other cancer treatments by prevention as well as treatment for cancer relapse are in development phases.

In addition, rising prevalence of complicated degenerative disorders such as age-related macular degeneration, Alzheimer’s disease, and Parkinson’s disease, especially in the aging population resulted in high investments in R&D to develop therapeutic solutions.

Regenerative medicine grabs the attention of the healthcare industry owing to its promising applications along with significant advances in supportive fields including tissue engineering, stem cells, gene therapy, drug discovery and nanotechnology. For instance, 3D printing over scaffold with stem cells to restore structure as well as functional characteristics of biological cells, tissues, and organs.

UK regenerative medicine market revenue by product type, 2014 – 2025 (USD Million)

uk-regenerative-medicine-market.png

Browse full research report on Regenerative Medicine Market: http://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market

Further Key Findings From the Study Suggest:

  • The global regenerative medicine demand exceeded USD 1.7 billion in 2016 and is expected to grow at a considerable rate over the forecast period owing to the presence of a strong looking product pipeline with anticipated commercializations just around the corner
  • Therapeutics emerged as the largest product segment in 2016 as it has a relatively high implementation and usage rate resulting in higher adoption
  • Global regenerative services demand for facilities such as tissue banks and cellular engineering tools is expected to drive demand in the segment
  • The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies with increased focus of dominant players in emerging economies is attributive to market growth. market.
  • Key players including Asterias Bio, Athersys, Integra LifeSciences Corpotation, and MiMedx are involved in complex technical cum financial partnerships with larger players in an attempt to expedite R&D

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-regenerative-medicine-market                                                                                          

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

Composites Market Is Projected To Grow Rapidly Due To Enhanced Demand In Electrical & Electronics, Wind Energy, Construction & Infrastructure, Pipes & Tanks & Marine Sector Till 2024: Grand View Research, Inc.

The global composites market is expected to reach USD 130.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing demand for composites in various applications including transportation, aerospace & defense, electrical & electronics, wind energy, construction & infrastructure, pipes & tanks, and marine is expected to drive market growth over the forecast period. The development of these end-user application segments is projected to fuel the industry expansion further.

Electrical & electronics accounted for 16.4% of the global volume market share in 2015. These materials are being increasingly used in electrical & electronics owing to their high arc resistance properties and dielectric strength. Growing demand for electronic gadgets, particularly wearable electronics, is expected to augment growth.

Transportation was the largest application of composites and is projected to witness significant gains at a CAGR of 7.5% from 2016 to 2024. The increase in road networks, especially in Asia Pacific, is expected to result in stimulating the growth of the market over the forecast period.

U.S. composites market revenue by application, 2013 – 2024, (USD Billion)

composites-market.png

Browse full research report on Composites Market: http://www.grandviewresearch.com/industry-analysis/composites-market

Further Key Findings From the Study Suggest:

  • The glass fiber market was estimated at USD 41.88 billion in 2015 and is projected to dominate the global composites market over the forecast period. Owing to its weather-resistant, surface texture varieties and lightweight properties, the global market for GFRP is projected to account for the largest share. Key market players are investing in the production of glass fibers especially in emerging countries such as India, Brazil and China owing to the growing demand from various application industries such as automotive, aerospace & defense, wind energy, and transportation.
  • North America is expected to witness a significant growth at a CAGR of 6.8% from 2016 to 2024 in terms of value. The automotive industry in this region has witnessed a significant growth in the recent years in terms of profitability and growth which has attributed to increasing the production of the auto sector. Furthermore, growing production of light commercial vehicles is expected to propel the growth of composites market over the forecast period.
  • Carbon fiber composites segment is supposed to create an avenue in the automotive industry owing to the high-value application and technological advancements. The segment accounted for 34.3% of the global market size in 2015. The major composites manufacturers are emphasizing on the expansion of production capacities and R&D activities to reduce the cost of CFRP.
  • Key industry players include Owens Corning, Toray Industries Inc., TenCate NV, SGL Carbon, Cytec Industries, Compagnie De Saint-Gobain, and Jushi Group Co. Ltd. These companies are focused on R&D activities to launch innovative products to strengthen their composites product portfolio and enhance their market presence.

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-composites-market                                                                                          

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

Eyewear Market To Gain Demand Quickly Due To Growing Awareness Regarding Proper Eye Health Among The Consumers Till 2024: Grand View Research, Inc.

The global eyewear market size is expected to reach USD 184.03 billion by 2024, according to a new report by Grand View Research, Inc. The increase in aging population and growing acceptance of eyewear, backed by rising disposable incomes of people worldwide are expected to play an important role in market growth. Moreover, growing awareness regarding proper eye health among the consumers is projected to strengthen the growth prospects over the forecast period.

Vendors are increasingly adopting innovative distribution channels including strategies such as vertical integration for organizational growth. The internet retailing has gained increasing popularity amongst the consumers as it enables them to place online orders for eyewear at better prices as compared to the conventional brick and mortar stores.

The increasing awareness regarding refractive surgeries, such as PRK and LASIK that reduce or eliminate individual’s dependency on corrective eyeglasses is a major factor impeding the industry growth. Such procedures are being progressively made affordable for a large percentage of the population across the developing regions.

North America Eyewear Market by Product, 2013 – 2024 (Volume, Million Units)

eyewear-industry.png

Browse full research report on Eyewear Market: http://www.grandviewresearch.com/industry-analysis/eyewear-industry

Further Key Findings From the Study Suggest:

  • Spectacles, which comprise frames and lenses, contributed to over 50% of the global eyewear market volume share in 2015 and are projected to witness stable growth owing to the high replacement rate of lenses and constantly changing prescriptions. Additionally, the introduction of progressive and high-index lenses has led to a surge in demand and is projected to continue over the next eight years.
  • Contact lenses contributed to over 30% of the global market volume share in 2015 and are poised for steady growth throughout the next eight years on account of the high degree of awareness among users coupled with the growing demand for the cosmetic lenses among the younger population. Moreover, the introduction of innovative easy-to-wear, cosmetic, and daily disposable lenses has positively impacted the sales of such products.
  • The European eyewear market was valued at close to USD 40 billion 2015 and is anticipated to witness steady growth throughout the forecast period.The presence of key eyeglasses vendors, such as Safilo Group S.p.A and Luxottica Group S.p.A in the region is anticipated to boost the regional eyeglasses sales volume in the coming years.The growth prospects for the Asia Pacific eyewear market seem very bullish owing to increase in purchasing power among consumers and wearer base expansion across the region.
  • Market participants are emphasizing onsupply chain integration,product innovation, and mergers and acquisitions, to gain a foothold in the industry. Establishment of an effective distribution network is the key to achieving global market expansion. The key industry participants include Luxottica Group S.p.A, Safilo Group S.p.A, Fielmann AG, CooperVision Inc., and Bausch + Lomb Inc.

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-eyewear-market                                                                                         

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

Trivalent Chromium Finishing Market Is Projected To Reach $379.1 Million By 2025: Grand View Research, Inc.

The global trivalent chromate finishing market is expected to reach USD 379.1 million by 2025, according to a new report by Grand View Research, Inc. The increasing awareness about health and safety issues coupled with regulatory mandates to enforce trivalent chromium as a replacement for hexavalent chromium is projected to fuel the market growth. In addition, rising demand from the European region is further expected to propel the demand over the forecast period.

In terms of revenue, decorative was the largest application segment in 2016 and the trend is anticipated to continue at a growth rate of 4.6% over the forecast period. Increasing need for improving the surface appearance of components is expected to contribute to the growth. Decorative chrome is being widely used on account of various properties such as stain and abrasion resistance. The extensive research to reduce the use of harmful chemicals in the chrome finishing process is boosting the demand for trivalent chrome finishing. The growth in construction activities due to the rising demand from the residential sector on account of easy credit availability is anticipated to drive the decorative chrome application in the architecture industry.

Trivalent chromate finished components are used in the manufacturing of various types of aircraft, which require precise dimensional measurements and corrosion resistant property. The increasing national security threats and mounting global tensions have boosted the budget spending for aerospace in the defense sector. The increased spending is expected to trigger the need for various ferrous and non-ferrous aerospace components, which use trivalent chromium finishing to improve the appearance and other properties of aircraft parts. These factors together are anticipated to boost trivalent chromium finishing market demand over the forecast period.

U.S. trivalent chromium finishing market, by system type, 2014 – 2025 (USD Million)

us-trivalent-chromium-finishing-market.png

Browse full research report on Trivalent Chromium Finishing Market: http://www.grandviewresearch.com/industry-analysis/trivalent-chromium-finishing-market

Further Key Findings From the Study Suggest:

  • Plating segment is expected to experience the fastest growth, in terms of value, at a CAGR of 4.7% from 2017 to 2025 as plating systems find application in various end-use industries such as automotive, hydraulics, and heavy machinery
  • Decorative emerged as the largest application segment, in terms of revenue, in 2016 and is estimated to be valued at USD 284.4 million by 2025. The growing popularity on account of corrosion and abrasion resistance properties is projected to drive the growth.
  • Automotive was estimated as the largest end-use industry due to different types of decorative and functional chrome being widely used for components in vehicle manufacturing
  • The U.S. trivalent chromium market, in terms of revenue, was valued at USD 44.07 million in 2016 and is estimated to reach USD 69.25 million by 2025. The automobile industry in the U.S. is projected to witness substantial growth over the next 8 years owing to the increasing demand for energy.
  • Key players including MacDermid Incorporated; Atotech Deutschland GmbH; Sarrel Group; Chem Processing, Inc.; Kakihara Industries Co., Ltd.; and Ronatec C2C, Inc. have a prominent presence in the global trivalent finishing market

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-trivalent-chromium-finishing-market                                                                                        

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com